Sudeep Das

发表

Radiolabeling of Theranostic Nanosystems.

M. Sarparanta, A. Airaksinen, Surachet Imlimthan, 2021, Advances in experimental medicine and biology.

Quantifying the CDK inhibitor VMY-1-103’s activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI

A. Üren, A. Ozcan, S. Karam, 2012, Cell cycle.

PSMA-bearing extracellular vesicles secreted from prostate cancer convert the microenvironment to a tumor-supporting, pro-angiogenic state

Evan P. Stater, K. Manova-Todorova, J. Grimm, 2022, bioRxiv.

Prospective testing of clinical Cerenkov luminescence imaging against standard-of-care nuclear imaging for tumour location

D. Tuch, J. Grimm, E. Pratt, 2022, Nature Biomedical Engineering.

Near-Infrared Quantum Dot and 89Zr Dual-Labeled Nanoparticles for in Vivo Cerenkov Imaging.

Travis M. Shaffer, J. Grimm, W. Mulder, 2017, Bioconjugate chemistry.

Cerenkov imaging.

Jan Grimm, J. Grimm, D. Thorek, 2014, Advances in cancer research.

Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model.

A. Scherz, J. Coleman, J. Grimm, 2019, European urology focus.

Cerenkov-Activated Sticky Tag for In Vivo Fluorescence Imaging

Jan Grimm, Katja Haedicke, J. Grimm, 2018, The Journal of Nuclear Medicine.

Discrimination of a colony stimulating factor subclass by a specific receptor on a macrophage cell line

L. Forman, S. Das, E. Stanley, 1980, Journal of cellular physiology.

Membrane-derived particles shed by PSMA-positive cells function as pro-angiogenic stimuli in tumors.

Y. Romin, Ning Fan, C. Masotti, 2023, Journal of controlled release : official journal of the Controlled Release Society.

Cerenkov-Activated Sticky Tag for In Vivo Fluorescence Imaging

J. Grimm, Katja Haedicke, Sudeep Das, 2018, The Journal of Nuclear Medicine.